Results
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
|
|
|
31.
|
|
|
|
32.
|
|
|
|
33.
|
|
|
|
34.
|
|
|
|
35.
|
|
|
|
36.
|
Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer. [electronic resource] by
- Dieras, V
- Marty, M
- Tubiana, N
- Corette, L
- Morvan, F
- Serin, D
- Mignot, L
- Chazard, M
- Garet, F
- Onetto, N
Producer: 19950914
In:
Seminars in oncology vol. 22
Availability: No items available.
|
|
|
37.
|
|
|
|
38.
|
|
|
|
39.
|
Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms. [electronic resource] by
- Tran, A
- Jullien, V
- Alexandre, J
- Rey, E
- Rabillon, F
- Girre, V
- Dieras, V
- Pons, G
- Goldwasser, F
- Tréluyer, J M
Producer: 20060705
In:
Clinical pharmacology and therapeutics vol. 79
Availability: No items available.
|
|
|
40.
|
Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response. [electronic resource] by
- Pierga, J-Y
- Mouret, E
- Laurence, V
- Diéras, V
- Savigioni, A
- Beuzeboc, P
- Dorval, T
- Palangié, T
- Jouve, M
- Pouillart, P
Producer: 20030701
In:
European journal of cancer (Oxford, England : 1990) vol. 39
Availability: No items available.
|